BRCA2 and cancer: Of 35 respondents who completed the CWS, 27 (77%) reported high levels of cancer worry (mean = 14, SD = 3.5), with no statistically significant difference in worry observed between BRCA1 and BRCA2 carriers (81% vs. 71%, respectively; p = 0.615).